List of Advanced Rx Recommended For Moderate to Severe UC Expands

The AGA has released an updated guideline on pharmacologic management of adult outpatients with UC that, for the ...

FEBRUARY 4, 2025

New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UC

The AGA has released a new, updated guideline on pharmacologic management of adult outpatients with ulcerative ...

NOVEMBER 26, 2024

Miguel Regueiro, MD, Picks His Favorite IBD Research From ACG 2024

Miguel Regueiro, MD, sat down with GEN to talk about some of his favorite studies focused on treating IBD.

NOVEMBER 19, 2024

Upadacitinib Versus Tofacitinib in UC; Etrasimod for Proctitis

Prospective studies that directly compare the efficacy of two different medications remain rare in our field, ...

NOVEMBER 15, 2024

The ABCs of Optimizing Drug Sequencing for IBD

The number of inflammatory bowel disease treatment options with different mechanisms of action has exploded over ...

OCTOBER 13, 2024

Combination Advanced Therapy in the Treatment of Inflammatory Bowel Disease

The development of effective biologics and small molecule targeted therapies has revolutionized the treatment of ...

SEPTEMBER 5, 2024

Study Looks at Infection Risk in Older IBD Patients on Immunosuppressive Therapies

Older adults represent a growing segment of patients with IBD, and several unique factors should be considered when ...

AUGUST 30, 2024

Miguel Regueiro, MD, Picks His Favorite IBD Research From DDW 2024

Digestive Disease Week 2024 was overflowing with research on all GI topics.

MAY 30, 2024

Equipoise at Risk With Placebo-Controlled Trials

The standard approach to randomized clinical trials for moderate to severe IBD causes harm to participants, ...

MAY 21, 2024

Treating Patients With Inflammatory Bowel Disease and Obesity

An estimated 41% of the US population is obese, including 22% of individuals aged 12 to 19 years, while nearly 1 of ...

MAY 10, 2024

Advanced Therapies for IBD Do Not Appear To Raise Thrombotic Risk

In patients with IBD, neither biologics nor small molecule targeted therapies increase the risk for major adverse ...

DECEMBER 29, 2023

Dual-Targeted Therapy in IBD Not Yet Ready for Prime Time

More evidence on the safety and efficacy of dual-targeted therapy for IBD is needed, according to presentations at ...

MARCH 20, 2023